Qui Tam

James F. Alderson, a client of Phillips & Cohen, was a financial officer with a Montana hospital when he was told that the hospital’s management company routinely filed fraudulent cost reports with...

Phillips & Cohen represented GlaxoSmithKline whistleblowers Matthew Burke and his co-relator in a qui tam case against GlaxoSmithKline that helped win a record-setting settlement of $3 billion from...

Judith King, a registered nurse, was a heart transplant coordinator at Sharp Memorial Hospital in San Diego. Phillips & Cohen brought a qui tam lawsuit against her employer on her behalf, alleging...

Phillips & Cohen represented Julie Darity in a qui tam lawsuit against her former employer C.R. Bard Inc. that alleged the company was offering illegal kickbacks to entice doctors and hospitals to...

Unnecessary care provided to patients — whether in hospitals, in skilled nursing facilities, through hospice programs or in other settings — not only defrauds Medicare and Medicaid, it also...

Sales and marketing tactics used by medical device companies, such as lucrative consulting agreements with doctors and off-label marketing, could violate the False Claims Act and could be the basis for...

Whistleblowers are essential for stopping medical loss ratio (MLR) fraud. They can do this by filing a “qui tam” (whistleblower) lawsuit. MLR fraud takes many forms, but usually involves reporting...

In the municipal bond market, some investment banking firms engaged in fraudulent schemes known as “yield-burning,” where they charged excessive prices for U.S. Treasury securities sold to...

When the government needs to procure highly specialized weapons systems, it frequently chooses to use a company that already makes them, known as a “sole source supplier.” This ensures a company...

Testimony of “Mr. ABC,” a confidential witness represented by Phillips & Cohen LLP, before the Senate Finance Committee – July 21, 2004. Mr. Chairman and Members of the Committee: I want...